Back to Search Start Over

Re‐evaluation of silicon dioxide (E 551) as a food additive in foods for infants below 16 weeks of age and follow‐up of its re‐evaluation as a food additive for uses in foods for all population groups

Authors :
EFSA Panel on Food Additives and Flavourings (FAF)
Maged Younes
Gabriele Aquilina
Laurence Castle
Gisela Degen
Karl‐Heinz Engel
Paul Fowler
Maria Jose Frutos Fernandez
Peter Fürst
Rainer Gürtler
Trine Husøy
Melania Manco
Wim Mennes
Peter Moldeus
Sabina Passamonti
Romina Shah
Ine Waalkens‐Berendsen
Matthew Wright
Cristina Andreoli
Maria Bastos
Diane Benford
Margherita Bignami
Claudia Bolognesi
Karlien Cheyns
Emanuela Corsini
Riccardo Crebelli
Birgit Dusemund
Rex Fitzgerald
Eric Gaffet
Katrin Loeschner
Francesca Marcon
Jan Mast
Manuela Mirat
Alicja Mortensen
Agnes Oomen
Josef Schlatter
Dominique Turck
Beate Ulbrich
Anna Undas
Christiane Vleminckx
Detlef Woelfle
Ruud Woutersen
Stefania Barmaz
Borana Dino
Gabriele Gagliardi
Sara Levorato
Elena Mazzoli
Alexis Nathanail
Ana Maria Rincon
Laura Ruggeri
Camilla Smeraldi
Alexandra Tard
Sam Vermeiren
Ursula Gundert‐Remy
Source :
EFSA Journal, Vol 22, Iss 10, Pp n/a-n/a (2024)
Publication Year :
2024
Publisher :
Wiley, 2024.

Abstract

Abstract The present opinion is the follow‐up of the conclusions and recommendations of the Scientific Opinion on the re‐evaluation of silicon dioxide (E 551) as a food additive relevant to the safety assessment for all age groups. In addition, the risk assessment of silicon dioxide (E 551) for its use in food for infants below 16 weeks of age is performed. Based on the newly available information on the characterisation of the SAS used as E 551 and following the principles of the 2021 EFSA Guidance on Particle‐TR, the conventional safety assessment has been complemented with nano‐specific considerations. Given the uncertainties resulting from the limitations of the database and in the absence of genotoxicity concern, the Panel considered that it is not appropriate to derive an acceptable daily intake (ADI) but applied the margin of exposure (MOE) approach for the risk assessment. The Panel concluded that the MOE should be at least 36 for not raising a safety concern. The calculated MOEs considering the dietary exposure estimates for all population groups using the refined non‐brand loyal scenario, estimated at the time of the 2018 re‐evaluation, were all above 36. The Panel concluded that E 551 does not raise a safety concern in all population groups at the reported uses and use levels. The use of E 551 in food for infants below 16 weeks of age in FC 13.1.1 and FC 13.1.5.1 does not raise a safety concern at the current exposure levels. The Panel also concluded that the technical data provided support an amendment of the specifications for E 551 laid down in Commission Regulation (EU) No 231/2012. The paucity of toxicological studies with proper dispersion protocol (with the exception of the genotoxicity studies) creates uncertainty in the present assessment of the potential toxicological effects related to the exposure to E 551 nanosize aggregates.

Details

Language :
English
ISSN :
18314732
Volume :
22
Issue :
10
Database :
Directory of Open Access Journals
Journal :
EFSA Journal
Publication Type :
Academic Journal
Accession number :
edsdoj.553de7e3e44d42b889ab1048ef895614
Document Type :
article
Full Text :
https://doi.org/10.2903/j.efsa.2024.8880